Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Karel Urbánek, Petr Šantavý, Ondřej Zuščich, Vendula Kubíčková, Danica Michaličková, Ondřej Slanař & Martin Šíma. (2023) Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass. Journal of Chemotherapy 35:7, pages 614-622.
Read now
Read now
Articles from other publishers (20)
R. Graham Cooks, Yunfei Feng, Kai‐Hung Huang, Nicolás M. Morato & Lingqi Qiu. (2023) Re‐Imagining Drug Discovery using Mass Spectrometry. Israel Journal of Chemistry 63:7-8.
Crossref
Crossref
Sherien A. Farrag, Azza H. Rageh, Hassan F. Askal & Gamal A. Saleh. (2023) HPTLC/MS and HPTLC/UV for monitoring of degradation behavior of some β-Lactam antibiotics mixtures under ambient storage conditions. Microchemical Journal 185, pages 108241.
Crossref
Crossref
Mahtabalsadat Mirjalili, Farid Zand, Iman Karimzadeh, Mansoor Masjedi, Golnar Sabetian, Ehsan Mirzaei & Afsaneh Vazin. (2023) The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial. Journal of Critical Care 73, pages 154170.
Crossref
Crossref
Varshaa Arer & Debasish Kar. (2023) Biochemical exploration of β-lactamase inhibitors. Frontiers in Genetics 13.
Crossref
Crossref
Silvana Alfei & Anna Maria Schito. (2022) β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources. Pharmaceuticals 15:4, pages 476.
Crossref
Crossref
Davide Carcione, Claudia Siracusa, Adela Sulejmani, Valerio Leoni & Jari Intra. (2021) Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use. Antibiotics 10:8, pages 995.
Crossref
Crossref
Joel A. Goldberg, Vijay Kumar, Elizabeth J. Spencer, Denton Hoyer, Steven H. Marshall, Andrea M. Hujer, Kristine M. Hujer, Christopher R. Bethel, Krisztina M. Papp-Wallace, Federico Perez, Michael R. Jacobs, David van Duin, Barry N. Kreiswirth, Focco van den Akker, Mark S. Plummer & Robert A. Bonomo. (2021) A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.. European Journal of Medicinal Chemistry 220, pages 113436.
Crossref
Crossref
Julio César García, Henry Robayo Amortegui & Adriana Carrasco Márquez. (2019) Multirresistencia de Acinetobacter baumannii: revisión narrativa. Acta Colombiana de Cuidado Intensivo 19:4, pages 219-226.
Crossref
Crossref
Anri Sawada, Kunio Kawanishi, Shohei Morikawa, Toshihiro Nakano, Mio Kodama, Mitihiro Mitobe, Sekiko Taneda, Junki Koike, Mamiko Ohara, Yoji Nagashima, Kosaku Nitta & Takahiro Mochizuki. (2018) Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review. BMC Nephrology 19:1.
Crossref
Crossref
Hossein Khalili, Lida Shojaei, Mostafa Mohammadi, Mohammad-Taghi Beigmohammadi, Alireza Abdollahi & Mahsa Doomanlou. (2018) Meropenem/colistin versus meropenem/ampicillin–sulbactam in the treatment of carbapenem-resistant pneumonia. Journal of Comparative Effectiveness Research 7:9, pages 901-911.
Crossref
Crossref
Adam B. Shapiro. (2017) Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam. Antimicrobial Agents and Chemotherapy 61:12.
Crossref
Crossref
Prachee Sathe, Sagar Maddani, Shilpa Kulkarni & Nita Munshi. (2017) Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone + sulbactam + disodium edetate) - A novel approach to spare carbapenems. Journal of Critical Care 41, pages 145-149.
Crossref
Crossref
Theodoros Karampatakis, Charalampos Antachopoulos, Athanassios Tsakris & Emmanuel Roilides. (2017)
Molecular epidemiology of carbapenem-resistant
Acinetobacter baumannii
in Greece: an extended review (2000–2015)
. Future Microbiology 12:9, pages 801-815.
Crossref
Crossref
John E. MazuskiJeffrey M. TessierAddison K. MayRobert G. SawyerEvan P. NadlerMatthew R. RosengartPhillip K. ChangPatrick J. O'NeillKevin P. MollenJared M. HustonJose J. DiazJrJrJose M. Prince. (2017) The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surgical Infections 18:1, pages 1-76.
Crossref
Crossref
Tosiharu Urakami, Yohei Hamada, Hiroki Magarihuchi, Hiroki Yamakuchi & Yosuke Aoki. (2014) Enterococcal endocarditis complicated with ruptured infected-intracranial aneurysm: With pharmacokinetic-pharmacodynamic documentation in proof of the successful antimicrobial treatment. Journal of Infection and Chemotherapy 20:12, pages 810-813.
Crossref
Crossref
J. Majcher-Peszynska, M. Loebermann, S. Klammt, S. Frimmel, R. G. Mundkowski, T. Welte, E. C. Reisinger & B. Drewelow. (2013) Ampicillin/sulbactam in elderly patients with community-acquired pneumonia. Infection 42:1, pages 79-87.
Crossref
Crossref
Chao-Wen ChenChi-Ming ChuChien-Jen MaYen-Shen ShanYung-Sung YehJaw-Yuan Wang. (2013) Prospective, Randomized, Study of Ampicillin-Sulbactam versus Moxifloxacin Monotherapy for the Treatment of Community-Acquired Complicated Intra-Abdominal Infections. Surgical Infections 14:4, pages 389-396.
Crossref
Crossref
Haiqing Chu, Lan Zhao, Minggui Wang, Yang Liu, Tao Gui & Jingbo Zhang. (2013) Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis. The Brazilian Journal of Infectious Diseases 17:4, pages 389-394.
Crossref
Crossref
Shanmugam Hemaiswarya & Mukesh Doble. (2010) Synergistic interaction of phenylpropanoids with antibiotics against bacteria. Journal of Medical Microbiology 59:12, pages 1469-1476.
Crossref
Crossref
N. Das, M. Dhanawat, B. Dash, R.C. Nagarwal & S.K. Shrivastava. (2010) Codrug: An efficient approach for drug optimization. European Journal of Pharmaceutical Sciences 41:5, pages 571-588.
Crossref
Crossref